Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review
Basic & Clinical Pharmacology & Toxicology · 2025-10 · 137 (4)
DOI: 10.1111/bcpt.70103 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 31.08.2025. Verfasst von Rhianna Griffiths und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Deprescriptions. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Anticholinergic medication use is increasing, particularly among older adults due to polypharmacy and comorbidities. High anticholinergic burden is linked to adverse outcomes such as reduced mobility and increased dementia risk. Acute hospital stays may offer an opportunity to address this often‐overlooked issue.
Aims
To examine the effects of deprescribing anticholinergic medications on outcomes in older hospitalised patients.
Methods
Medline, Web of Science, Cochrane Library and Embase were searched from inception to September 2024. Studies included hospital‐based deprescribing or medication review interventions targeting anticholinergic burden in patients aged ≥ 65 years. Narrative synthesis followed SWiM guidelines, with quality assessment using JBI Checklists.
Results
From 2042 records, eight studies met inclusion criteria. Designs included cohort ( n = 4) and pre‐post quasi‐experimental ( n = 4), with follow‐up durations of up to 3 months. All reported medication‐related outcomes; four assessed acceptability, one included clinical outcomes, and none examined safety. Six studies reported reductions in anticholinergic burden scores; three showed significant decreases in the proportion of patients prescribed anticholinergics, and two noted fewer potentially inappropriate medications. Most recommended changes were implemented.
Conclusion
Deprescribing interventions in hospital appear acceptable and effective in reducing anticholinergic burden. However, evidence on clinical outcomes, costs and safety is limited. Further RCTs with longer follow‐up are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, University of Southampton, Southampton, UK.
- NIHR Applied Research Collaboration Wessex, University of Southampton, Southampton, UK.
- University Hospital Southampton NHS Foundation Trust, Southampton, UK.
- NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.
ORCID-Profile: Kinda Ibrahim
Zitieren
APA
Griffiths, R., Lim, S., Lin, J., Bates, A., Jones, L., & Ibrahim, K. (2025). Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review. Basic & Clinical Pharmacology & Toxicology, 137(4). https://doi.org/10.1111/bcpt.70103
Vancouver
Griffiths R, Lim S, Lin J, Bates A, Jones L, Ibrahim K. Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review. Basic & Clinical Pharmacology & Toxicology. 2025;137(4). doi:10.1111/bcpt.70103
BibTeX
@article{Griffiths2025,
author = {Griffiths, Rhianna and Lim, Steve and Lin, Julian and Bates, Andrew and Jones, Liam and Ibrahim, Kinda},
title = {Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {137},
number = {4},
doi = {10.1111/bcpt.70103}
}
EUVIMED